(Q85217276)
Statements
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study (English)
Anne Etienne
Raynier Devillier
Emilie Romeo
Aude Charbonnier
Evelyne D'incan
Benjamin Esterni
Christine Arnoulet
18 October 2010